Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

February 15, 2017 (Vol. 37, No. 4)

Tumor Biomarkers Guide Immunotherapy

Diverse Immuno-Oncology Approaches Call for Diverse Biomarkers

  • Tumor biomarkers act as important contextual cues or signals of cancer status. “If there are T cells infiltrating your cancer, you are going to do better than if you don’t have them. For almost every cancer, immune infiltrates are prognostic markers for better overall outcome,” says Bernard A. Fox, Ph.D., ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.